• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Promnix 0.4
    / Taro


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Modified-Release Capsules

    30 X 0.4 mg

    partial basket chart 86496 16771

    Related information


    Dosage

    One capsule a day after breakfast or first meal of the day, recommended at the same time each day.
    See prescribing information for full details.


    Indications

    Treatment of functional symptoms of benign prostatic hyperplasia (BPH).


    Contra-Indications

    Hypersensitivity to tamsulosin HCl or to any of the excipients. History of orthostatic hypotension, severe hepatic insufficiency.


    Special Precautions

    Blood pressure may drop in individual cases during treatment. Patients with micturition syncope. Digital rectal examination, determination of PSA should be performed before treatment and at regular intervals afterwards. Severely renally impaired patients (creatinine clearance of


    Side Effects

    Dizziness, abnormal ejaculation.
    See prescribing information for full details.


    Drug interactions

    Diclofenac, warfarin, other alfa-1-adrenoceptor antagonists.
    See prescribing information for full details.


    Manufacturer
    Synthon BV
    CLOSE